Related Experiment Video
Updated: Jun 22, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Hypoglycemic herbs and their action mechanisms.
Hongxiang Hui1, George Tang, Vay Liang W Go
1Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. Huihongx@gmail.com
Chinese Medicine
|June 16, 2009
Summary
This review explores popular herbs like ginseng and bitter melon for diabetes management. These natural remedies offer diverse mechanisms to help lower blood glucose levels effectively.
Area of Science:
- Phytochemistry
- Pharmacology
- Metabolic Disorders
Background:
- Conventional diabetes treatments focus on insulin sensitivity, production, or blood glucose reduction.
- Herbal remedies for diabetes exhibit complex or paradoxical hypoglycemic effects.
Purpose of the Study:
- To review recent findings on popular hypoglycemic herbs and commercial herbal formulations for diabetes.
- To elucidate the mechanisms of action for these natural antidiabetic agents.
Main Methods:
- Literature review of scientific findings on hypoglycemic herbs.
- Discussion of specific herbs: ginseng, bitter melon, Coptis chinensis.
- Analysis of commercial herbal preparations: ADHF, Jiangtangkeli, YGD, BN.
Main Results:
- Herbal efficacy stems from mechanisms like increased insulin secretion, enhanced glucose uptake, and inhibited glucose absorption/production.
- Specific herbs and formulations demonstrate varied approaches to glucose regulation.
Conclusions:
- Popular hypoglycemic herbs and formulations offer multiple pathways to manage blood glucose levels.
- Further research into these natural agents can provide valuable insights for diabetes treatment.
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...